로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > CTGF

CTGF

요약

Name:Connective tissue growth factor
Target Synonym:Cellular communication network factor 2,IBP-8,Hypertrophic chondrocyte-specific protein 24,IGF-binding protein 8,IGFBP-8,Connective tissue growth factor,IGFBP8,CCN2,Insulin-like growth factor-binding protein 8,HCS24,CCN family member 2,CTGF,NOV2
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Approved

제품 리스트 구매

일부의 생물활성 데이터

CTF-M52Hc-BLI
 CTGF BLI

Loaded Monoclonal Anti-Human CTGF Antibody, Human IgG1 on AHC Biosensor, can bind Mouse CTGF, His Tag (Cat. No. CTF-M52Hc) with an affinity constant of 2.46 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

CTF-H52H5-BLI
 CTGF BLI

Loaded Monoclonal Anti-Human CTGF Antibody, Human IgG1 on AHC Biosensor, can bind Human CTGF, His Tag (Cat. No. CTF-H52H5) with an affinity constant of 6.29 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Synonym Name

CCN2,NOV2,HCS24,IGFBP8,IBP-8,IGFBP-8,IGF-binding protein 8

Background

Connective Tissue Growth Factor (CTGF), also known as CCN2, is a member of the CCN (CCN1-6) family of modular matricellular proteins. Like other CCN proteins, mature human CTGF consists of IGF-binding protein domain, a vWF-C domain, a TSP-1 domain, and a cysteine knot heparin-binding domain. CTGF promotes proliferation and differentiation of chondrocytes. Mediates heparin- and divalent cation-dependent cell adhesion in many cell types including fibroblasts, myofibroblasts, endothelial and epithelial cells. Enhances fibroblast growth factor-induced DNA synthesis. Analysis of CCN2 function in vivo has focused primarily on its key role as a mediator of excess ECM synthesis in multiple fibrotic diseases.

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Penicillamine Approved Valeant Distamine, Pemine, Trisorcin, Cuprimine, Cupramine, Trolovol Mainland China Hepatolenticular Degeneration; Lead Poisoning; Arthritis, Rheumatoid; Heavy Metal Poisoning Sichuan Pharmaceutical Co Ltd 1970-12-04 Heavy Metal Poisoning; Arthritis, Rheumatoid; Hepatolenticular Degeneration; Cystinuria; Lead Poisoning Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
SHR-1906 SHR-1906 Phase 1 Clinical Guangdong Hengrui Pharmaceutical Co Ltd Idiopathic Pulmonary Fibrosis Details
RXI-109 RXI-109 Rxi Pharmaceutical Details
EXC-001 EXC-001; PF-6473871; PF-06473871 Ionis Pharmaceuticals Inc Details
LEM-S401 LEM-S401; LEMS401 Phase 1 Clinical Lemonex Inc Cicatrix Details
PRS-220 PRS-220 Phase 1 Clinical Pieris Pharmaceuticals Idiopathic Pulmonary Fibrosis Details
Pamrevlumab FG-3019 Phase 3 Clinical Fibrogen Inc Diabetes Mellitus, Type 2; Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Glomerulosclerosis, Focal Segmental; Muscular Dystrophy, Duchenne; Diabetic Nephropathies; Diabetes Mellitus Details
OLX-10010 cp-asiCTGF; OLX-101A; OLX-10010; BMT-101; OLX-101 Phase 2 Clinical Olix Pharmaceuticals Inc Pulmonary Fibrosis; Wet Macular Degeneration; Macular Degeneration; Cicatrix, Hypertrophic Details

This web search service is supported by Google Inc.

totop